glp-1 gastrointestinal obstruction law office in west virginia semaglutide firm louisiana gi semaglutide diarrhea law firm in semaglutide diarrhea lawyer in west glp-1 constipation law office in

The REDEFINE 1 trial found that when evaluating the treatment effect regardless of whether patients stayed on treatment, those treated with CagriSema achieved weight loss of 20.4% (from an average baseline body weight of 236 lb) at 68 weeks versus 3.0% (from an average baseline body weight of 235 lb) for the placebo group which was statistically significant

China approved the drug in June 2025, and the higher-dose application is already under review

Share Cycle syncing, a wellness practice that aligns lifestyle choices with the various phases of the menstrual cycle, has gained popularity for its potential to optimize female health and well-being

pneumoniae [96]